Table of Contents

Articles

• You have access

  Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1

  Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser

  Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771
• You have access

  The Vascular Smooth Muscle Type I Angiotensin II Receptor mRNA Is Destabilized by Cyclic AMP-Elevating Agents

  Xiaofei Wang, Georg Nickenig and T. J. Murphy

  Molecular Pharmacology November 1997, 52 (5) 781-787; DOI: https://doi.org/10.1124/mol.52.5.781
• You have access

  Ligand-Induced Phosphorylation, Clustering, and Desensitization of A₁ Adenosine Receptors

  Francisco Ciruela, Carles Saura, Enric I. Canela, Josefa Mallol, Carmen Lluís and Rafael Franco

  Molecular Pharmacology November 1997, 52 (5) 788-797; DOI: https://doi.org/10.1124/mol.52.5.788
• You have access

  Fludarabine-Mediated Repair Inhibition of Cisplatin-Induced DNA Lesions in Human Chronic Myelogenous Leukemia-Blast Crisis K562 Cells: Induction of Synergistic Cytotoxicity Independent of Reversal of Apoptosis Resistance

  Lan Li, Michael J. Keating, William Plunkett and Li-Ying Yang

  Molecular Pharmacology November 1997, 52 (5) 798-806; DOI: https://doi.org/10.1124/mol.52.5.798
• You have access

  Ligand Binding Pocket of the Human Somatostatin Receptor 5: Mutational Analysis of the Extracellular Domains

  Michael T. Greenwood, Nedim Hukovic, Ujendra Kumar, Rosemarie Panetta, Siv A. Hjorth, Coimbatore B. Srikant and Yogesh C. Patel

  Molecular Pharmacology November 1997, 52 (5) 807-814; DOI: https://doi.org/10.1124/mol.52.5.807
• You have access

  Evidence for Nucleotide Excision Repair as a Modifying Factor ofO ⁶-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines

  Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci

  Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815
• You have access

  Phosphorylation of the Kv2.1 K⁺ Channel Alters Voltage-Dependent Activation

  Hideyuki Murakoshi, Gongyi Shi, Robert H. Scannevin and James S. Trimmer

  Molecular Pharmacology November 1997, 52 (5) 821-828; DOI: https://doi.org/10.1124/mol.52.5.821
• You have access

  The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs

  Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill

  Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829
• You have access

  Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site

  Brian B. Hasinoff, Andrew M. Creighton, Hanna Kozlowska, Padmakumari Thampatty, William P. Allan and Jack C. Yalowich

  Molecular Pharmacology November 1997, 52 (5) 839-845; DOI: https://doi.org/10.1124/mol.52.5.839
• You have access

  Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A₃ Receptor and Evidence that Degranulation Is Mediated by the A_2B Receptor

  John A. Auchampach, Xiaowei Jin, Tina C. Wan, George H. Caughey and Joel Linden

  Molecular Pharmacology November 1997, 52 (5) 846-860; DOI: https://doi.org/10.1124/mol.52.5.846
• You have access

  N-Glycosylation Is Not a Prerequisite for Glutamate Receptor Function but Is Essential for Lectin Modulation

  Inga Everts, Carmen Villmann and Michael Hollmann

  Molecular Pharmacology November 1997, 52 (5) 861-873; DOI: https://doi.org/10.1124/mol.52.5.861
• You have access

  Key Amino Acids in the γ Subunit of the γ-Aminobutyric Acid_A Receptor that Determine Ligand Binding and Modulation at the Benzodiazepine Site

  Peter B. Wingrove, Sally A. Thompson, Keith A. Wafford and Paul J. Whiting

  Molecular Pharmacology November 1997, 52 (5) 874-881; DOI: https://doi.org/10.1124/mol.52.5.874
• You have access

  Epirubicin-Induced Oxidative DNA Damage and Evidence for Its Repair in Lymphocytes of Cancer Patients Who Are Undergoing Chemotherapy

  Ryszard Olinski, Pawel Jaruga, Marek Foksinski, Karol Bialkowski and Jerzy Tujakowski

  Molecular Pharmacology November 1997, 52 (5) 882-885; DOI: https://doi.org/10.1124/mol.52.5.882
• You have access

  Potentiation and Inhibition of Neuronal Nicotinic Receptors by Atropine: Competitive and Noncompetitive Effects

  Ruud Zwart and Henk P. M. Vijverberg

  Molecular Pharmacology November 1997, 52 (5) 886-895; DOI: https://doi.org/10.1124/mol.52.5.886
• You have access

  Down-regulation of μ-Opioid Receptor by Full but Not Partial Agonists Is Independent of G Protein Coupling

  Nirmala Yabaluri and Fedor Medzihradsky

  Molecular Pharmacology November 1997, 52 (5) 896-902; DOI: https://doi.org/10.1124/mol.52.5.896
• You have access

  Expression of Methylthioadenosine Phosphorylase cDNA inp16 ⁻, MTAP ⁻Malignant Cells: Restoration of Methylthioadenosine Phosphorylase-Dependent Salvage Pathways and Alterations of Sensitivity to Inhibitors of Purine de novo Synthesis

  Zhi-Hao Chen, Olufunmilayo I. Olopade and Todd M. Savarese

  Molecular Pharmacology November 1997, 52 (5) 903-911; DOI: https://doi.org/10.1124/mol.52.5.903
• You have access

  Role of Free Radicals in Primary Nonfunction of Marginal Fatty Grafts from Rats Treated Acutely with Ethanol

  Zhi Zhong, Henry Connor, Robert F. Stachlewitz, Moritz von Frankenberg, Ronald P. Mason, John J. Lemasters and Ronald G. Thurman

  Molecular Pharmacology November 1997, 52 (5) 912-919; DOI: https://doi.org/10.1124/mol.52.5.912